Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT00868270
Other study ID # HY55-08
Secondary ID
Status Not yet recruiting
Phase N/A
First received March 22, 2009
Last updated March 22, 2009
Start date May 2009

Study information

Verified date March 2009
Source Hillel Yaffe Medical Center
Contact Hassan Jassar, MD
Phone 972-4-630-4332
Email hasjassar@hotmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The prevalence of kidney scarring after UTI is approximately 5-57%. UTIs are caused mainly by bacteria that cause local and systemic immunological reaction that are accompanied by cytokines. These cytokines are a main factor in the inflammatory process. They are produced by leukocytes, macrophages, fibroblasts, endothelial cells and epithelial cells in the kidney tissue. Interleukin 6 and 8 (IL-6 IL-8) were found in high levels in the urine of children and adults who suffer from UTIs. Other studies on animals have found a relationship between inflammatory reaction and scarring in the kidney. We hypothesize that we will find a similar relationship between the level of IL-6, IL-8 in the urine during acute pyelonephritis in children and the probability of kidney scarring.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 35
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A to 7 Years
Eligibility Inclusion Criteria:

- Children aged 0-7

- First episode febrile UTI

Exclusion Criteria:

- Recurrent UTI

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Hillel Yaffe Medical Center Hadera

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary High prevalence of kidney scarring in children with high levels of urine interleukins six months No